Health Care [ 7/12 ] | Biotechnology [ 56/74 ]
NASDAQ | Common Stock
Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities.
It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need.
Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 15, 26 | -0.62 Increased by +53.03% | -0.59 Decreased by -5.08% |
| Mar 27, 26 | -0.97 Increased by +10.19% | -3.78 Increased by +74.34% |
| Nov 13, 25 | -2.01 Increased by +21.18% | -3.39 Increased by +40.71% |
| Aug 13, 25 | -3.24 Decreased by -41.48% | -3.01 Decreased by -7.64% |
| May 8, 25 | -1.32 Increased by +64.71% | -2.23 Increased by +40.81% |
| Mar 19, 25 | -1.08 Increased by +45.73% | -3.65 Increased by +70.41% |
| Nov 11, 24 | -2.55 Decreased by -390.38% | -2.10 Decreased by -21.43% |
| Aug 13, 24 | -2.29 Decreased by -1.54 K% | -2.98 Increased by +23.15% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 26 | 0.00 Decreased by N/A% | -4.20 M Increased by +85.09% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 25 | 0.00 Decreased by -100.00% | -8.19 M Increased by +31.14% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 25 | 0.00 Decreased by N/A% | -13.59 M Increased by +40.98% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 25 | 0.00 Decreased by N/A% | -21.39 M Decreased by -43.42% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 25 | 0.00 Decreased by N/A% | -28.20 M Decreased by -16.04% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 24 | 3.99 M Decreased by -48.03% | -11.89 M Increased by +7.97% | Decreased by -298.42% Decreased by -77.09% |
| Sep 30, 24 | 0.00 Decreased by N/A% | -23.02 M Increased by +65.86% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 24 | 0.00 Decreased by N/A% | -14.92 M Increased by +20.07% | Decreased by N/A% Decreased by N/A% |